Pinto ACMD, Nunes RDM, Nogueira IA, Fischer B, Lucas R, Girao-Carmona VCC, De Oliveira VLS, Amaral FA, Schett G, Rocha FAC (2022)
Publication Type: Journal article
Publication year: 2022
Book Volume: 13
Article Number: 1049368
DOI: 10.3389/fimmu.2022.1049368
In view of the crucial role of tumor necrosis factor (TNF) in joint destruction, TNF inhibitors, including neutralizing anti-TNF antibodies and soluble TNF receptor constructs, are commonly used therapeutics for the treatment of arthropathies like rheumatoid arthritis (RA). However, not all patients achieve remission; moreover, there is a risk of increased susceptibility to infection with these agents. Spatially distinct from its receptor binding sites, TNF harbors a lectin-like domain, which exerts unique functions that can be mimicked by the 17 residue solnatide peptide. This domain binds to specific oligosaccharides such as N′N′-diacetylchitobiose and directly target the α subunit of the epithelial sodium channel. Solnatide was shown to have anti-inflammatory actions in acute lung injury and glomerulonephritis models. In this study, we evaluated whether the lectin-like domain of TNF can mitigate the development of immune-mediated arthritis in mice. In an antigen-induced arthritis model, solnatide reduced cell influx and release of pro-inflammatory mediators into the joints, associated with reduction in edema and tissue damage, as compared to controls indicating that TNF has anti-inflammatory effects in an acute model of joint inflammation via its lectin-like domain.
APA:
Pinto, A.C.M.D., Nunes, R.D.M., Nogueira, I.A., Fischer, B., Lucas, R., Girao-Carmona, V.C.C.,... Rocha, F.A.C. (2022). Potent anti-inflammatory activity of the lectin-like domain of TNF in joints. Frontiers in Immunology, 13. https://dx.doi.org/10.3389/fimmu.2022.1049368
MLA:
Pinto, Ana Carolina Matias Dinelly, et al. "Potent anti-inflammatory activity of the lectin-like domain of TNF in joints." Frontiers in Immunology 13 (2022).
BibTeX: Download